RBOT insider plans Rule 144 sale of Class A common stock

Rhea-AI Filing Summary

Vicarious Surgical Inc. (RBOT) insider Adam Sachs filed a notice to sell Class A common stock under Rule 144. The filing reports a proposed sale of 816 shares through UBS Financial Services Inc. on the NYSE, with an aggregate market value of $2,292.96. Shares outstanding were 5,894,273 at the time referenced, giving context for the relative size of the transaction. The shares to be sold came from a restricted stock lapse on 11/19/2025, when 2,377 shares of Class A common stock were acquired.

The filing also lists sales by the same seller during the prior three months, including 817 shares sold on 08/20/2025 and 463 shares sold on 09/03/2025. By signing the notice, the seller represents that he is not aware of any material adverse, nonpublic information about the company’s current or future operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	816	2292.96	5894273	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	11/19/2025	Restricted Stock Lapse	Vicarious Surgical Inc			2377	11/19/2025	Restricted Stock Lapse

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	08/20/2025	817	4763
Adam Sachs 78 4th Ave Waltham MA 02451	Class A Common Stock	09/03/2025	463	2546

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for Vicarious Surgical (RBOT) disclose?

The Form 144 discloses that an insider plans to sell 816 shares of Vicarious Surgical Inc. Class A common stock under Rule 144 through a broker on the NYSE.

How many Vicarious Surgical (RBOT) shares does the insider plan to sell now?

The notice states an intended sale of 816 shares of Class A common stock, with an aggregate market value of $2,292.96.

What is the recent trading history for this insider in Vicarious Surgical (RBOT) shares?

Over the prior three months, the insider sold 817 shares on 08/20/2025 and 463 shares on 09/03/2025 of Vicarious Surgical Class A common stock.

How many Vicarious Surgical (RBOT) shares were outstanding at the time referenced?

The filing notes that 5,894,273 shares of Class A common stock were outstanding at the referenced time, providing context for the size of the planned sale.

How did the insider acquire the Vicarious Surgical (RBOT) shares being sold?

The shares to be sold were acquired on 11/19/2025 through a restricted stock lapse from Vicarious Surgical Inc., in an amount of 2,377 shares.

What representation does the seller make in this Vicarious Surgical (RBOT) Form 144?

By signing the notice, the seller represents that he does not know any material adverse information about Vicarious Surgical’s current or prospective operations that has not been publicly disclosed.